Movano (Movano) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is Movano Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Movano is: No Data: Cannot be evaluated.

Competitive Comparison of Movano's Risk Assessment

For the Medical Devices subindustry, Movano's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Movano's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Movano's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Movano's Risk Assessment falls into.

Movano (NAS:MOVE) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Movano Risk Assessment Related Terms

Thank you for viewing the detailed overview of Movano's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Movano (Movano) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Movano Inc (NAS:MOVE) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

6800 Koll Center Parkway, Pleasanton, CA, USA, 94566

Website

https://www.movano.com

Movano Inc is a health-focused technology company developing simple, smart, and personalized devices designed to help individuals on their health journey maintain good health today and prevent and manage chronic diseases in the future. It is developing a proprietary platform that uses Radio Frequency (RF) technology. It enables the creation of low-cost and scalable sensors that fit into wearable and other small form factors.

Executives

Jeremy Cogan	officer: CFO	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Michael Aaron Leabman	director, officer: CEO and President	207 VERITAS CT, SAN RAMON CA 94582
Emily Fairbairn	director	10 ORINDA VIEW ROAD, ORINDA CA 94563
John Mastrototaro	director	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Brian Cullinan	officer: CFO	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Nan Kirsten Forte	director	111 EIGHTH AVENUE, NEW YORK NY 10011
Ruben Caballero	director	C/O RESONANT INC. 10900 STONELAKE BLVD., SUITE 100, OFFICE 02-130, AUSTIN TX 78759
Dvine Irrevocable Trust	10 percent owner	6200 STONERIDGE MALL RD., SUITE 300, PLEASANTON CA 94588
Gregory S Tamkin	10 percent owner	303 RAY STREET, PLEASANTON CA 94566
Dorsey & Whitney Trust Co Llc	10 percent owner	401 EAST EIGHTH STREET, SUITE 319, SIOUX FALLS SD 57103
William Tai-wei Ho	10 percent owner	C/O IN8BIO, INC., 79 MADISON AVENUE, NEW YORK NY 10016